QDEL
QuidelOrtho Corp
NASDAQ · Healthcare · Medical - Instruments & Supplies · US
$12.76
−1.16%Oct 15, 2026, 22:10 UTC
QuidelOrtho announced equity awards to two newly hired non-executive employees under its 2026 Inducement Plan as an inducement to employment.
Source:Sep 23, 2026, 20:47 UTC
QuidelOrtho Corporation amended its existing credit agreement with Bank of America, N.A. as administrative agent, resetting financial covenant levels through the fiscal quarter ending September 30, 2029 and adjusting interest rate pricing and fees.
Aug 17, 2026, 19:06 UTC
QuidelOrtho cut its 2026 outlook, citing deeper China and respiratory risks, while cash use and rising debt add pressure despite resilient core growth.
Source:Aug 6, 2026, 20:05 UTC
QuidelOrtho Corporation reported second quarter 2026 financial results with total revenue of $631 million, up 3% as reported and 2% in constant currency, driven by Labs and Point of Care growth.
Jun 27, 2026, 12:28 UTC
QuidelOrtho plans to sell its testing unit for $1.5 billion.
Source:Jun 23, 2026, 00:00 UTC
QuidelOrtho Corp appointed Micah Young as Chief Financial Officer, effective July 6, 2026.